21 results on '"Gómez, P."'
Search Results
2. Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial)
3. 2193P Real-world evidence of the impact of immunotherapy (IT) on overall survival (OS) of patients (p) with malignant pleural mesothelioma (MPM) adjusted for tumor histology
4. 1476P Outcomes to first-line pembrolizumab in patients with advanced NSCLC and high PD-L1 expression: A Spanish multicentric study
5. Management of the axilla in early breast cancer patients in the genomic era
6. Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors
7. 1637P Impact of immune-related adverse events (irAEs) and survival (OS) in a cohort of MPM patients (p) treated with immunotherapy (IT)
8. 1007P Mechanisms of primary and secondary resistance to RET inhibitors in patients with RET-positive advanced NSCLC
9. 126P The HLA I composite score and VHIO immune gene-expression signature (VIGex) as selection tools to explore the tumor microenvironment (TME) in patients (pts) treated with immunotherapy (IT)
10. Targeted therapy in advanced colon cancer: the role of new therapies
11. Corrections to “Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors”
12. 1733P Analysis of chemotherapy (Ct) efficacy according to histology in malignant pleural mesothelioma (MPM) patients (p)
13. 35P Toxicity and safety of novel immuno-oncology (IO) treatments after prior immune checkpoint inhibitors (ICIs) exposure
14. P-207 - Clinical and molecular characteristics of biliary tract carcinoma using next-generation sequencing
15. 1344P - Thermal liquid biopsy as a new tool for lung cancer patients diagnostic: Pilot study
16. 478P - In the pathway to response: Is aflibercept an optimal treatment for RASwt mCRC patients after progression to 1st line containing anti-EGFR?
17. 784O - Docetaxel (D) with androgen suppression (AS) for high-risk localized prostate cancer (HrPC) patients (pts) who relapsed PSA after radical prostatectomy (RP) and/or radiotherapy (RT): A randomized phase III trial
18. 1390P - Changing trends in HIV and cancer
19. 344P - TERT as a prognostic factor for gliomas progression-free survival (PFS)
20. LBA8 - A Phase III Randomized, Double-Blind, Trial Comparing Sorafenib Plus Capecitabine Versus Placebo Plus Capecitabine in the Treatment of Locally Advanced or Metastatic Her2-Negative Breast Cancer (Resilience)
21. Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.